MEDIFAST INC

For the period ended Dec 31, 2025. Filed Feb 17, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 17, 2026

MED$12.81+0.6%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

As of December 31, 2025 and 2024

(U.S. dollars in thousands, except par value)

	2025	2024
ASSETS
Current Assets
Cash and cash equivalents	$89,303	$90,928
Inventories, net	20,228	42,421
Investments	77,970	71,416
Income taxes, prepaid	5,116	—
Prepaid expenses and other current assets	9,066	9,639
Total current assets	201,683	214,404
Property, plant and equipment - net of accumulated depreciation	31,230	37,527
Right-of-use assets	7,232	11,155
Other assets	7,828	9,667
Deferred tax assets, net	—	11,460
TOTAL ASSETS	$247,973	$284,213
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable and accrued expenses	$38,359	$56,494
Income taxes payable	—	1,485
Current lease obligations	4,603	6,182
Total current liabilities	42,962	64,161
Lease obligations, net of current lease obligations	6,091	9,943
Total liabilities	49,053	74,104
Commitments (Note 12)
Stockholders' Equity
Common stock, par value 0.001 per share: 20,000 shares authorized;
10,991 and 10,938 issued and outstanding
at December 31, 2025 and December 31, 2024	11	11
Additional paid-in capital	40,406	33,136
Accumulated other comprehensive income	234	180
Retained earnings	158,269	176,782
Total stockholders' equity	198,920	210,109
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$247,973	$284,213

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.